Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs LunaRx

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, LunaRx a 65. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

LunaRx

#316 · Grade C · Watch List

Est. first month

From $199/mo (starting dose, compounded)

Save ~85% vs brand-name
Get this deal Full LunaRx review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 65 an est. $99/mo first month, with no teaser step-up baked in. LunaRx isn't out of it: Shoppers who want adults who want a GLP-1 program with muscle-protective peptides and a built-in off-ramp taper.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDLunaRx
Value Score89 (A)65 (C)
Est. first month$99/moFrom $199/mo (starting dose, compounded)
Save vs brand-name~93%~85%
Semaglutide$99/moFrom $199/mo (starting dose, compounded)
Tirzepatide$139/moNot disclosed
Both moleculesYesNo
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
72
bmiMD: 95. LunaRx: 72.
84
No Teaser-Rate Bait
64
bmiMD: 84. LunaRx: 64.
98
Nationwide Availability
45
bmiMD: 98. LunaRx: 45.
94
Both Molecules
70
bmiMD: 94. LunaRx: 70.
82
Easy Cancellation
58
bmiMD: 82. LunaRx: 58.
70
Reputation
68
bmiMD: 70. LunaRx: 68.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

LunaRx

LunaRx is a bilingual (English/Spanish) telehealth practice from LunaRx LLC built around "metabolic recomposition" — compounded GLP-1 therapy paired with muscle-protective peptides and a structured off-ramp…

Why it's a deal

  • Pairs GLP-1 with muscle-protective peptides (e.g., CJC-1295/Ipamorelin, NAD+) to defend lean mass during fat loss
  • Structured, physician-directed off-ramp taper with GI-reset support instead of an indefinite prescription
  • Bilingual care in English and Spanish across intake, messaging, and consults
  • Care directed through a named independent medical group (CareNexus Clinic PC); $0 charged if you are not approved
  • Published clinical support hours (Mon–Fri, CT) with phone, email, and secure messaging; cancel anytime

The fine print

  • Only a "from $199/mo" starting price is published; tirzepatide and per-tier pricing are confirmed only after a provider review
  • Compounding pharmacy partners are not named on the site — a transparency gap
  • No LegitScript or PCAB verification is displayed
  • States served are not published; the site claims "telehealth nationwide" but the Terms limit service to states where LunaRx is licensed
  • Compounded medications are not FDA-approved (the site discloses this)
Get the bmiMD deal Get the LunaRx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to LunaRx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.